Nissan Motor Co., currently undergoing a major restructuring, finds itself once again at a critical crossroads. On November 6, 2025, the company announced its consolidated financial results for the first half of fiscal year 2025 (April–September), posting a net loss of ¥221.9 billion, a dramatic deterioration from a ¥19.2 billion profit in the same period last year.

By Honourway Asia Pacific Limited

On October 24, 2025, Toyota Motor Corporation announced—via an official press release—the end of an era for car enthusiasts worldwide: production of the pure sports car GR Supra will cease in March 2026. On its official website, Toyota quietly posted a note of gratitude: “We would like to express our sincere thanks to the many customers who have supported us over the years.” This was more than a routine notice about the discontinuation of a single model; it signaled the closing of a major chapter in Japan’s sports-car history.

By Honourway Asia Pacific Limited

A critical announcement determining the fate of “independence” and “commercialization” in Japan’s private space development has been made. Space One Co., Ltd., a space startup headquartered in Tokyo, officially announced on December 15, 2025, that it will launch the third vehicle of its small solid-fuel rocket, KAIROS, on February 25, 2026.

By Honourway Asia Pacific Limited

On April 8, 2025, Japan’s regenerative medicine reached a historic turning point. Cuorips Inc., a biotech venture spun out of Osaka University, announced it had submitted a marketing authorization application to Japan’s Ministry of Health, Labour and Welfare (MHLW) for a “cardiomyocyte sheet” created from human induced pluripotent stem (iPS) cells. This is believed to be the world’s first marketing application aiming to commercialize a regenerative medicine product using iPS cells, and it has generated great anticipation across the scientific and medical communities.

By Honourway Asia Pacific Limited